Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-difference trial.
Saved in:
| Title: | Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-difference trial. |
|---|---|
| Authors: | Landmesser U; Deutsches Herzzentrum der Charité, Klinik für Kardiologie, Angiologie und Intensivmedizin, Hindenburgdamm 30, 12203 Berlin, Germany.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany., Laufs U; Department of Cardiology, Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany., Schatz U; Department of Internal Medicine III, Faculty of Medicine at the Technical University of Dresden, University Hospital Carl Gustav Carus, Dresden, Germany., Winzer EB; Department for Internal Medicine and Cardiology, Heart Center Dresden, University Clinic, Technische Universität Dresden, Dresden, Germany., Nowak B; CCB, Cardioangiologisches Centrum Bethanien, Frankfurt a.M., Germany., Kassner U; Division of Lipid Disorders, Department of Endocrinology, Charité-Universitätsmedizin Berlin, corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Gouni-Berthold I; Center for Endocrinology, Diabetes and Preventive Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Esteban A; Clinical Development, Novartis Pharma AG, Basel, Switzerland., Lubyayi L; Advanced Quantitative Sciences, Novartis Pharmaceuticals UK Ltd, London, UK., Krueger A; Global Medical Affairs, Cardio Renal Metabolism, Novartis Pharma AG, Basel, Switzerland., Hentschke C; Evidence Generation, Novartis Pharma GmbH, Nürnberg, Bayern, Germany., Wilke A; Kardiologische Praxis Papenburg, Papenburg, Germany., Winkelmann BR; Study Center, ClinPhenomics CVC GmbH, Frankfurt, Germany., Achouba A; Global Medical Affairs, ASCVD, Novartis Pharma AG, Basel, Switzerland., Banach M; Faculty of Medicine, the John Paul II Catholic University of Lublin, Lublin, Poland.; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Preventive Cardiology and Lipidology, Medical University of Lodz, Lodz, Poland. |
| Source: | European heart journal [Eur Heart J] 2026 Jul 01; Vol. 47 (25), pp. 3241-3253. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN: 1522-9645 (Electronic) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40884558 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-difference trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Landmesser+U%22">Landmesser U</searchLink>; Deutsches Herzzentrum der Charité, Klinik für Kardiologie, Angiologie und Intensivmedizin, Hindenburgdamm 30, 12203 Berlin, Germany.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Laufs+U%22">Laufs U</searchLink>; Department of Cardiology, Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Schatz+U%22">Schatz U</searchLink>; Department of Internal Medicine III, Faculty of Medicine at the Technical University of Dresden, University Hospital Carl Gustav Carus, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Winzer+EB%22">Winzer EB</searchLink>; Department for Internal Medicine and Cardiology, Heart Center Dresden, University Clinic, Technische Universität Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Nowak+B%22">Nowak B</searchLink>; CCB, Cardioangiologisches Centrum Bethanien, Frankfurt a.M., Germany.<br /><searchLink fieldCode="AU" term="%22Kassner+U%22">Kassner U</searchLink>; Division of Lipid Disorders, Department of Endocrinology, Charité-Universitätsmedizin Berlin, corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Gouni-Berthold+I%22">Gouni-Berthold I</searchLink>; Center for Endocrinology, Diabetes and Preventive Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Esteban+A%22">Esteban A</searchLink>; Clinical Development, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lubyayi+L%22">Lubyayi L</searchLink>; Advanced Quantitative Sciences, Novartis Pharmaceuticals UK Ltd, London, UK.<br /><searchLink fieldCode="AU" term="%22Krueger+A%22">Krueger A</searchLink>; Global Medical Affairs, Cardio Renal Metabolism, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hentschke+C%22">Hentschke C</searchLink>; Evidence Generation, Novartis Pharma GmbH, Nürnberg, Bayern, Germany.<br /><searchLink fieldCode="AU" term="%22Wilke+A%22">Wilke A</searchLink>; Kardiologische Praxis Papenburg, Papenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Winkelmann+BR%22">Winkelmann BR</searchLink>; Study Center, ClinPhenomics CVC GmbH, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Achouba+A%22">Achouba A</searchLink>; Global Medical Affairs, ASCVD, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Banach+M%22">Banach M</searchLink>; Faculty of Medicine, the John Paul II Catholic University of Lublin, Lublin, Poland.; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Preventive Cardiology and Lipidology, Medical University of Lodz, Lodz, Poland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228006263%22">European heart journal</searchLink> [Eur Heart J] 2026 Jul 01; Vol. 47 (25), pp. 3241-3253. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8006263 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1522-9645 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220195668X%22">0195668X </searchLink><i>NLM ISO Abbreviation: </i>Eur Heart J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40884558 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/eurheartj/ehaf685 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3241 Titles: – TitleFull: Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-difference trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Landmesser U – PersonEntity: Name: NameFull: Laufs U – PersonEntity: Name: NameFull: Schatz U – PersonEntity: Name: NameFull: Winzer EB – PersonEntity: Name: NameFull: Nowak B – PersonEntity: Name: NameFull: Kassner U – PersonEntity: Name: NameFull: Gouni-Berthold I – PersonEntity: Name: NameFull: Esteban A – PersonEntity: Name: NameFull: Lubyayi L – PersonEntity: Name: NameFull: Krueger A – PersonEntity: Name: NameFull: Hentschke C – PersonEntity: Name: NameFull: Wilke A – PersonEntity: Name: NameFull: Winkelmann BR – PersonEntity: Name: NameFull: Achouba A – PersonEntity: Name: NameFull: Banach M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1522-9645 Numbering: – Type: volume Value: 47 – Type: issue Value: 25 Titles: – TitleFull: European heart journal Type: main |
| ResultId | 1 |